2012-07-05 05:08:55 - Fast Market Research recommends "Carefusion Health Medical Device Company Intelligence Report" from Espicom Business Intelligence, now available
CareFusion, formerly the Clinical and Medical Products division of Cardinal Health, serves the healthcare industry with products and services designed to help hospitals improve the safety and quality of care. The company offers product lines in the areas of intravenous (IV) infusion, medication and supply dispensing, respiratory care, infection prevention and surgical instruments. Its primary product brands include:
Alaris IV infusion systems that feature the company's proprietary Guardrails software, an application that alerts the clinician when a parameter is outside the institution's pre-established limitations for that medication, thereby helping to reduce IV medication errors;
Pyxis automated medication dispensing systems that are designed to provide medication management and Pyxis automated medical supply dispensing systems;
AVEA and Pulmonetic Systems ventilation and respiratory products, and Jaeger
and SensorMedics pulmonary products;
ChloraPrep products that help prevent vascular and surgical-site infections and MedMined software and surveillance services that help target and reduce hospital-acquired infections (HAIs); and
V. Mueller surgical instruments and related products and services.
Full Report Details at
- www.fastmr.com/prod/434451_carefusion_health_medical_device_comp ..
CareFusion's separation from Cardinal Health was completed on 31st August 2009. In connection with the spin-off, CareFusion distributed a cash dividend in the amount of US$1,374 million to Cardinal Health, and Cardinal Health contributed the majority of the businesses comprising its Clinical and Medical Products segment to CareFusion and distributed approximately 81% of the company's outstanding common shares to its shareholders. Cardinal Health retained approximately 19% of CareFusion's outstanding common shares. As a condition to the separation, Cardinal Health is required to dispose of the remaining 19% of CareFusion's common shares within five years of the distribution date.
Certain lines of business that manufacture and sell surgical and exam gloves, drapes and apparel and fluid management products in the US market, that were historically managed by CareFusion prior to the spin-off and were part of the Clinical and Medical Products business of Cardinal Health, were retained by Cardinal Health. CareFusion has an agreement with Cardinal Health to distribute these products in international markets.
Leading up to the spin-off from Cardinal Health, CareFusion organised its business into two reportable segments: Critical Care Technologies and Medical Technologies & Services. At the end of June 2011, the company made the decision to realign its business into two new global operating segments. As a result of this realignment, CareFusion also made a determination to realign its reportable segments with the new operating segments. As a result, as of the beginning of FY2012, CareFusion re-segmented its business into two new operating and reportable divisions: Medical Systems and Procedural Solutions.
Medical Systems - this segment is organised around CareFusion's medical equipment business. Within this segment, the company operates its dispensing technologies, infusion systems and respiratory technologies business lines:
Dispensing Technologies - equipment and related services for medication and supply dispensing.
Infusion Systems - infusion pumps and dedicated disposable infusion sets and accessories.
Respiratory Technologies - respiratory ventilators and disposable ventilator circuits and accessories.
Procedural Solutions - organised around CareFusion's disposable products business. Within the Procedural Solutions segment, the company operates its infection prevention, medical supplies and specialty disposables business lines:
Infection Prevention - single-use skin antiseptic and other patient-preparation products and non-dedicated disposable infusion administration sets and accessories.
Medical Specialties - interventional specialty products.
CareFusion employs approximately 14,000 people worldwide.
This company report provides
Overview Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company's major competitors?
Key recent events in an "at a glance" format
Financial Review Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Investigates the company's aims and its areas of focus
Core product areas, key brands, product approvals and launches
Research and Development How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?
Manufacturing and Distribution Identifying the company's manufacturing locations
Sales and marketing facilities
Agreements With whom has the company reached agreements and what do they involve?
Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Key Corporate Events
About Espicom Business Intelligence
Espicom Business Intelligence is a highly-regarded and established provider of business intelligence services. Founded in 1982 as MDIS Publications Ltd, the company changed its name to Espicom in 1992. Initially a publisher in a wide range of industries such as power generation and telecommunications, they now focus on the global pharmaceutical and medical device sectors. View more research from Espicom Business Intelligence at www.fastmr.com/catalog/publishers.aspx?pubid=1025
About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.
For more information about these or related research reports, please visit our website at www.fastmr.com
or call us at 1.800.844.8156.